Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01288339Phase 2Completed
Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
PrincipalinvestigatorStart date: 2010-11-08
NCT01285778Phase 2Completed
Vectibix for the Treatment of Anal Cancer
Anal Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2010-10-01

Research Network

Collaboration Network

56 collaborators·99 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joan Maurel, MD

Hospital Clinic of Barcelona

Related
3 trials

Shared therapeutic areas:

Anal Squamous Cell CarcinomaMetastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+2 more
Collaborated on 2 trials
Similarity Score28%

Marta Martín, MD

Hospital de la Santa Creu i Sant Pau de Barcelona

Related
2 trials

Shared therapeutic areas:

Anal Squamous Cell CarcinomaMetastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+2 more
Collaborated on 2 trials
Similarity Score28%

Uriel Bohn, MD

Hosptial Dr. Negrin de Las Palmas de Gran Canaria

Related
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Antonia Salud, MD

Hospital Arnau de Vilanova de Lleida

Related
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Carlos Fernández-Martos, MD

Instituto Valenciano de Oncología

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Carles Bosch, MD

Hospital Dr. Peset de Valencia

Related
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Juana Maria Cano, MD

Hosptial General de Ciudad Real

Related
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Carlos Fernandez-Martos, MD

Instituto Valenciano de Oncología de Valencia

Related
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Maria José Safont, MD

Hospital General Universitario de Valencia

Related
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Isabel Sevilla, MD

Hospital Universitario Virgen de la Victoria (Málaga)

Related
1 trials

Shared therapeutic areas:

Anal Squamous Cell Carcinoma

Worked with same sponsors:

AmgenGrupo Espanol Multidisciplinario del Cancer Digestivo+1 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01288339Phase 2PrincipalInvestigator

Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Completed
NCT01285778Phase 2PrincipalInvestigator

Vectibix for the Treatment of Anal Cancer

Anal Squamous Cell Carcinoma
Completed
NCT00941135Phase 2PrincipalInvestigator

Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab

Laryngeal Neoplasms
Terminated

All 3 trials loaded